IVI Virtual State Forum 2020: Building Vaccine Diplomacy & Advocacy - IVI

News and stories
Careers
Events
Contact us
Donate
한국어

Who We Are
What We Do
- Overview
- Discover
- Develop
- Deliver
- Build Capacity
- Disease Areas
  - Cholera
  - Typhoid
  - Dengue
  - MERS
  - Schistosomiasis
  - Chikungunya
  - COVID-19
  - AMR
    - RADAAR
  - Other
Where We Work
- Overview Map
- IVI Member States
Our Impact

✕

IVI Virtual State Forum 2020: Building Vaccine Diplomacy & Advocacy

Home
events
IVI Virtual State Forum 2020: Building Vaccine Diplomacy & Advocacy

IVI Virtual State Forum 2020: Building Vaccine Diplomacy & Advocacy

Loading…

Related posts

SKYCovione™ is South Korea's first homegrown vaccine to achieve licensure. Photo courtesy of SK bioscience.

07/02/2022

SK bioscience’s COVID-19 vaccine approved for use by Republic of Korea

News and stories
Press Releases
Announcements
IVI in the Media
Blog
Newsletters

Subscribe to usemail addressSubscribe

Social Media

Stay Connected

Vision & Mission
Why Vaccines
IVI in Brief
History
Director General’s Message
Policies
- Gender equality
- Environmental Sustainability
State Parties/Signatories

Leadership
Senior Management
Our Partners

Overview
Discover
Develop
Deliver
Build Capacity

Disease Areas
- Cholera
- Typhoid
- Dengue
- MERS
- Schistosomiasis
- Chikungunya
- COVID-19
- Other

Where We Work

Overview map
IVI Member State Relations

Journal Publications
International Vaccinology Course
News and stories
Annual Reports & Financial Statement

Korea Support Committee for IVI (KSC)

Copyright 2022 International Vaccine Institute. All Rights Reserved.

No translations available for this page

News and stories
Careers
Events
Contact us
Donate
한국어